GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (XAMS:BAI) » Definitions » Pre-Tax Income

Benevolent AI (XAMS:BAI) Pre-Tax Income : €-84.53 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Benevolent AI Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Benevolent AI's pretax income for the six months ended in Dec. 2023 was €-33.58 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was €-84.53 Mil. Benevolent AI's pretax margin was -1,422.11%.


Benevolent AI Pre-Tax Income Historical Data

The historical data trend for Benevolent AI's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI Pre-Tax Income Chart

Benevolent AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial -70.40 -72.53 -143.24 -206.80 -84.33

Benevolent AI Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only -88.24 -173.46 -35.60 -50.96 -33.58

Competitive Comparison of Benevolent AI's Pre-Tax Income

For the Biotechnology subindustry, Benevolent AI's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benevolent AI's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benevolent AI's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Benevolent AI's Pre-Tax Income falls into.


;
;

Benevolent AI Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Benevolent AI's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-88.819+0+-0.378+4.481+0.38700000000001
=-84.33

Benevolent AI's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-41.739+0+-0.174+2.185+6.152
=-33.58

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-84.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Benevolent AI  (XAMS:BAI) Pre-Tax Income Explanation

Benevolent AI's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-33.576/2.361
=-1,422.11%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Benevolent AI Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Benevolent AI's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Benevolent AI Business Description

Traded in Other Exchanges
Address
4-8 Maple Street, London, GBR, W1T 5HD
Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.

Benevolent AI Headlines